Biomimetic Dual‐Driven Heterojunction Nanomotors for Targeted Catalytic Immunotherapy of Glioblastoma
Authors:
- 9 November 2024
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (9) , 2416265
Abstract
The existence of the blood–brain barrier (BBB) and the characteristics of the immunosuppressive microenvironment in glioblastoma (GBM) present significant challenges for targeted GBM therapy. To address this, a biomimetic hybrid cell membrane‐modified dual‐driven heterojunction nanomotor (HM@MnO2‐AuNR‐SiO2) is proposed for targeted GBM treatment. These nanomotors are designed to bypass the BBB and target glioma regions by mimicking the surface characteristics of GBM and macrophage membranes. More importantly, the MnO2‐AuNR‐SiO2 heterojunction structure enables dual‐driven propulsion through near‐infrared‐II (NIR‐II) light and oxygen bubbles, allowing effective treatment at deep tumor sites. Meanwhile, the plasmonic AuNR‐MnO2 heterostructure facilitates the separation of electron–hole pairs and generates reactive oxygen species (ROS), inducing immunogenic tumor cell death under NIR‐II laser irradiation. Furthermore, MnO2 in the tumor microenvironment reacts to release Mn2+ ions, activating the cGAS‐STING pathway and enhancing antitumor immunity. In vitro and in vivo experiments demonstrate that these dual‐driven biomimetic nanomotors achieve active targeting and deep tumor infiltration, promoting M1 macrophage polarization, dendritic cell maturation, and effector T‐cell activation, thereby enhancing GBM catalysis and immunotherapy through ROS production and STING pathway activation.Keywords
Funding Information
- National Natural Science Foundation of China (32071322)
This publication has 63 references indexed in Scilit:
- Second Near‐Infrared Phototheranostics with cGAS‐STING‐Activating Capacity for Photothermal ImmunotherapyAdvanced Functional Materials, 2024
- Design of Near Infrared Light‐Powered Copper Phyllosilicate Nanomotors for Cuproptosis‐Based Synergistic Cancer TherapyAdvanced Functional Materials, 2024
- Tumor Microenvironment‐Responsive Nanoparticles Amplifying STING Signaling Pathway for Cancer ImmunotherapyAdvanced Materials, 2023
- Augmenting Immunotherapy via Bioinspired MOF‐Based ROS Homeostasis Disruptor with Nanozyme‐Cascade ReactionAdvanced Materials, 2023
- Sono‐Driven STING Activation using Semiconducting Polymeric Nanoagonists for Precision Sono‐Immunotherapy of Head and Neck Squamous Cell CarcinomaAdvanced Materials, 2023
- Manganese‐Based Tumor ImmunotherapyAdvanced Materials, 2023
- Self‐Thermophoretic Nanoparticles Enhance Intestinal Mucus Penetration and Reduce Pathogenic Bacteria Interception in Colorectal CancerAdvanced Functional Materials, 2023
- Brain Co‐Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma ChemotherapyAdvanced Materials, 2022
- Engineering Radiosensitizer‐Based Metal‐Phenolic Networks Potentiate STING Pathway Activation for Advanced RadiotherapyAdvanced Materials, 2021
- GSH‐Responsive Radiosensitizers with Deep Penetration Ability for Multimodal Imaging‐Guided Synergistic Radio‐Chemodynamic Cancer TherapyAdvanced Functional Materials, 2021